Anti‐inflammatory therapy with tumour necrosis factor inhibitors is associated with reduced risk of major adverse cardiovascular events in psoriasis

Journal of the European Academy of Dermatology and Venereology, EarlyView.


https://ift.tt/2Kun4DC